Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Compounds for bone diseases, neuropathy discovered at Takeda

June 1, 1998

AxyS Pharmaceuticals and Glaxo Wellcome discontinue diabetes/obesity collaboration

May 27, 1998

New beta3-adrenoceptor agonists discovered by SmithKline Beecham

May 27, 1998

The role of HMG-CoA reductase inhibitors in organ transplantation

May 27, 1998

Bio-Technology General and Serono announce copromotion agreement

May 26, 1998

Takeda establishes independent U.S. company, begins partnership with Lilly

May 26, 1998

Beneficial repercussions on cardiovascular morbidity of weight reduction with orlistat

May 25, 1998

NPY receptor ligands claimed by Agouron

May 25, 1998

Muse approved in South Africa

May 25, 1998

Thienopyridines for impotence, heart failure in development at Merck KGaA

May 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...